View Older Stories View More Recent Stories

Oct 27, 2020 04:01PM Personalis to Participate in Upcoming Investor Conferences
Oct 22, 2020 04:01PM Personalis to Announce Third Quarter 2020 Financial Results on November 5, 2020
Oct 15, 2020 09:02AM Personalis to Participate in Immuno Series US Virtual Meeting
Oct 1, 2020 01:20PM Personalis, Inc. to Present at IO Combinations 360˚
Sep 29, 2020 04:05PM Personalis to Participate in Digital World CB & CDx Meeting
Sep 17, 2020 08:07AM Personalis, Inc. (PSNL) Receives Contract Extension and New Task Order From the VA’s Million Veteran Program
Sep 17, 2020 08:03AM Personalis Receives Contract Extension and New Task Order From the VA’s Million Veteran Program – Total Awarded to Date Now $175M
Sep 15, 2020 04:01PM Personalis Strengthens Commercial Team with the Appointment of New Head of Population Genomics
Sep 2, 2020 04:01PM Personalis to Participate in Upcoming Investor Conferences
Aug 12, 2020 04:01PM Personalis to Participate at the Needham Virtual Cancer Diagnostics 1x1 Conference
Aug 6, 2020 04:01PM Personalis Reports Second Quarter 2020 Financial Results
Aug 3, 2020 08:17AM Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy Platform
Jul 23, 2020 04:01PM Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020
Jul 16, 2020 05:15PM Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 16, 2020 08:32AM Personalis Further Expands Leadership Team With Appointment of Leslie Grab, VP of Intellectual Property and John Lyle, VP of Assay Research and Development
Jun 24, 2020 08:00AM Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP
Jun 22, 2020 08:00AM Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting
Jun 18, 2020 06:15PM Personalis to Participate in European Association for Cancer Research (EACR) 2020 Virtual Congress
Jun 16, 2020 01:00PM Personalis to Present at the Precision Breast Cancer Summit
Jun 16, 2020 08:00AM Personalis Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 10, 2020 04:05PM Personalis Announces a Partnership with Berry Genomics for China Expansion
Jun 2, 2020 08:00AM Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics
May 29, 2020 11:08AM Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting
May 7, 2020 04:01PM Personalis Reports First Quarter 2020 Financial Results
May 5, 2020 02:00PM Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel
Apr 29, 2020 04:05PM Personalis to Participate at Upcoming Investor Conferences
Apr 29, 2020 12:00PM Personalis Announces Renewed Clinical Laboratory Accreditation from College of American Pathologists
Apr 23, 2020 04:05PM Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020
Apr 21, 2020 11:31AM Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Apr 21, 2020 03:00AM Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Apr 14, 2020 11:45AM Personalis, Inc. Expands Genomics Portfolio Across Disease Areas With Launch of Pharma Research Solutions for Use in Early Drug Discovery and Preclinical Studies
Mar 31, 2020 04:05PM Personalis to Participate at the 19th Annual Needham Virtual Healthcare Conference
Mar 25, 2020 04:01PM Personalis Reports Fourth Quarter and Full Year 2019 Financial Results
Mar 11, 2020 04:05PM Personalis to Announce Fourth Quarter and Full Year 2019 Financial Results on March 25, 2020
Feb 26, 2020 08:00AM Personalis, Inc. to Present at Immuno-Oncology 360˚ Conference
Feb 18, 2020 04:05PM Personalis, Inc. to Present at Biomarkers Series UK 2020 Conference
Feb 18, 2020 08:00AM Personalis to Participate at the Cowen 40th Annual Health Care Conference
Feb 11, 2020 01:00PM Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program
Feb 11, 2020 09:13AM Advaxis (ADXS) Gains 8% on Agreement with Personalis for ADXS-503 Trial
Feb 11, 2020 08:00AM Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program
Jan 22, 2020 12:15PM Personalis, Inc. to Present at Precision Medicine World Conference 2020
Jan 7, 2020 05:38PM Personalis, Inc. (PSNL) Announces the Launch of the NeXT Dx Test
Jan 7, 2020 05:15PM Personalis, Inc. Announces the Launch of the NeXT Dx™ Test, a Comprehensive Genomic Cancer Profiling Test Enabling Advanced Composite Biomarkers for Cancer Treatment
Dec 10, 2019 08:00PM Personalis, Inc. to Present at ESMO Immuno-Oncology Congress 2019
Nov 21, 2019 08:00AM Personalis, Inc. to Present at NeoAg Summit US 2019
Nov 19, 2019 04:05PM Personalis to Present at Upcoming Investor Conferences
Nov 19, 2019 08:00AM Personalis, Inc. Announces Collaboration With Merck KGaA, Darmstadt, Germany, to Identify and Develop Novel Biomarkers for Cancer Therapies
Nov 17, 2019 04:30PM Personalis, Inc. to Present New Data at the AACR Tumor Immunology and Immunotherapy Conference
Nov 13, 2019 04:05PM Personalis Reports Third Quarter 2019 Financial Results
Nov 12, 2019 05:30PM Personalis, Inc. Expands Oncology Portfolio With the Launch of Cancer Whole Genome Sequencing Services
View More Recent Stories View Older Stories